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A B S T R A C T
Two ﬂavone glycosides, apigenin-6-C-glucoside (1) and lutelin-6-C-glucoside (2), and an anomeric mixture of
2,3-dygalloyl-4,6-HHDP-D-glucose (3a/3b) were isolated for the ﬁrst time from Geranium molle L., a medicinal
plant used in the folk medicine of northeast of Portugal for the treatment of a variety of ailments, including
cancer. The cytotoxic activity of the isolated compounds was assessed against several human tumour cell lines
and non-tumour porcine liver primary cells. The anomeric mixture of ellagitannins 3a/3b, with the two anomers
showing considerably diﬀerent hydrophobicities, was found to be signiﬁcantly cytotoxic against cancer cells,
with only moderate hepatotoxicity.
1. Introduction
Since ancient civilizations the products of natural origin have been
used in traditional medicines for the prevention or treatment of dif-
ferent ailments. In recent years, phenolic compounds, which are the
most abundant secondary metabolites in plants, have been the subject
of much interest for being endowed with various bioactivities (Cong-
Cong et al., 2017; Visioli et al., 2011). Phenolic compounds act as
scavengers of reactive oxygen species and are considered to help reduce
the risk of development of many diseases such as atherosclerosis, dia-
betes, hypertension, cardiovascular and neuro-degenerative diseases
and cancer (Cory et al., 2018; Marquardt and Watson, 2014). The dif-
ferent biological activities of phenolic compounds are most likely due to
their large structural diversity. The present valorisation of medicinal
plants is largely based on the richness of these plants in phenolic
compounds (Tungmunnithum et al., 2018).
Geranium molle L. is a plant belonging to the Geraniaceae family and
it is distributed throughout the world (Aedo et al., 1998a, 1998b).
Despite its widespread distribution, apparently only one ethno-
pharmacological study refers the use of this plant in folk medicine.
Flowering aerial parts and roots of wild G. molle are traditionally used
in the northeast of Portugal to prepare decoctions and infusions for the
treatment of various disorders, including cancer (Neves et al., 2009).
Unlike many other species from Geranium genus, there seems to exist no
reference to its bioactivity or phytochemical composition with the ex-
ception of two recent studies disclosed by our group (Graça et al., 2016,
2018). Firstly, we carried out a preliminary assessment of the bioac-
tivity and the determination of the phenolic composition of diﬀerent
aqueous and organic extracts of the plant (Graça et al., 2016). Fol-
lowing this, the fractionation of the two more bioactive extracts -
acetone and MeOH - was carried out by gradient elution column
chromatography on silica gel (Graça et al., 2018). The antioxidant ac-
tivity and the cytotoxicity of each fraction against selected human
cancer cell lines were assessed and the phenolic proﬁle was determined.
The fractionation gave rise to fractions with lower structural com-
plexity, allowing the identiﬁcation of a greater number of compounds.
The objectives of the present work were the isolation of the major
phenolic compounds present in the fractions with the best bioactivity
by semipreparative HPLC, their structural characterization and the
evaluation of the cytotoxic activity against the same cancer cells lines,
in order to accesses the contribution of each compound for the observed
cytotoxicity of the bioactive fractions.
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2. Materials and methods
2.1. General experimental procedures
Melting points were measured in a melting point apparatus
equipped with a binocular microscope (Rotoquímica, Portugal) and are
uncorrected. NMR spectra were acquired on Bruker NEO-500 spectro-
meter (1H 500MHz, 13C 125MHz) equipped with a TXI probe. Data sets
were processed using Bruker Topspin 4.0.2 software. Samples were
dissolved in methanol-d4 in NMR glass tubes (5 mm). Chemical shifts
are expressed in ppm relative to the residual proton signal in deuterated
solvent. Chemical shifts are reported as position (δ in ppm), multi-
plicity, coupling constant (J in Hz), integral. The attributions of protons
and carbons were achieved by analysis of 2D experiments (COSY, HSQC
and HMBC). High resolution electrospray ionization time-of-ﬂight mass
spectra (HRMS ESI-TOF) were determined on Apex-Q FT-ICR or
micrOTOF mass spectrometers (Bruker, Germany). Semipreparative
HPLC separations were conducted on a DIONEX UltiMate 3000 in-
strument equipped with a RP-C18 (ACE, 5 μm, 250mm×10mm)
column. Analytical HPLC was performed with a DIONEX UltiMate 3000
instrument equipped with a RP-C18 (ACE, 5 μm, 250mm×4.6mm)
column. Solvents for HPLC separation were of chromatographic grade.
2.2. Plant material
Geranium molle L. was collected in Serra da Nogueira, Bragança,
north-eastern Portugal, in March 2015. The botanical identiﬁcation was
conﬁrmed by the agronomist Dra. Ana Maria Carvalho of the School of
Agriculture, Instituto Politécnico de Bragança (Trás-os-Montes,
Portugal). Voucher specimens (Geranium molle L. ETBO 61 of 30 of
March of 2015) are deposited at the herbarium of the Escola Superior
Agrária de Bragança (BRESA).
2.3. Preparation of the fractions
The starting acetone extract was obtained by sequential extraction
of the lyophilized whole plant with diﬀerent organic solvents (n-
hexane, CH2Cl2, EtOAc, acetone and MeOH) as described previously
(Graça et al., 2016). The crude acetone extract was then fractionated by
gradient elution column chromatography in silica gel using an eluo-
tropic series comprising CH3Cl, EtOAc, acetone, MeOH and HCO2H to
yield 12 fractions (FA1 to FA12) as described (Graça et al., 2018).
2.4. Isolation of compounds
Fractions FA4, FA5 and FA6 were separated using semipreparative
HPLC. The eluent system was composed by 1% aqueous HCO2H (eluent
A) and MeOH (eluent B) and a ﬂow rate of 1mL/min was used. The
elution was performed as follows: 0–130min, 5–65% MeOH;
130–134min, 65–5% MeOH; 134–150min, 5% MeOH. The injection
volume was 2mL. A total of 105 sub-fractions of 1.43mL each were
collected. The purity of each subfraction was conﬁrmed by analytical
HPLC, using the eluent mixture and the ﬂow rate described above. The
program used was 0–65min, 5–65% MeOH; 65–67min, 65–5% MeOH;
67–75min, 5% MeOH. The injection volume was 50 μL. The subfrac-
tions containing the same single compound were combined, con-
centrated under reduced pressure and lyophilized. Fraction FA4 (1 g)
furnished a mixture of 2,3-dygalloyl-4,6-HHDP-α-D-glucose (3a) and
2,3-dygalloyl-4,6-HHDP-β-D-glucose (3b) (50mg). Fraction FA5
(400mg) yielded apigenin-6-C-glucoside (1) (1mg) and lutelin-6-C-
glucoside (2) (8mg). Fraction FA6 (500mg) furnished 2 (5 mg).
Apigenin-6-C-glucoside (1): Yellow, amorphous powder; M.p.
221–222 °C; UV (MeOH) λmax 213, 271, 336 nm; 1H and 13C NMR data
(CD3OD): Table 1; HRMS (ESI-TOF) m/z: 433.1124 ([M + H]+, calc.
for C21H21O10: 433.1129); m/z: 455.0936 ([M+Na]+, calc. for
C21H20NaO10: 455.0949).
Luteolin-6-C-glucoside (2): Yellow, amorphous powder; M.p.
242–243 °C; UV (MeOH) λmax 212, 270, 349 nm; 1H NMR and 13C NMR
data (CD3OD): Table 1; HRMS (ESI-TOF) m/z: 449.1077 ([M + H]+,
calc. for C21H21O11: 449.1078); m/z: 471.0899 ([M+Na]+, calc. for
C21H20NaO11: 471.0898).
2,3-Dygalloyl-4,6-HHDP-α-D-glucose (3a)/2,3-Dygalloyl-4,6-
HHDP-β-D-glucose (3b): White powder. UV (MeOH) λmax 218, 276 nm;
1H NMR and 13C NMR data (CD3OD): Table 2; HRMS (ESI-TOF) m/z:
787.0993 ([M + H]+, calc. for C34H27O22: 787.0988); m/z: 809.0822
([M+Na]+, calc. for C34H26NaO22: 809.0808).
2.5. Cytotoxicity in human tumour cell lines and hepatotoxicity in non-
tumour cells
Compounds 1-3 were dissolved in H2O/MeOH 80/20 (v/v) to obtain
stock solutions with a concentration of 8mg/mL. The ﬁnal solutions,
with a range of concentrations from 6.25 to 400 μg/mL, were prepared
by serial dilution of the stock solutions. In vitro cytotoxicity was eval-
uated by the Sulforhodamine B (SRB) assay using four human tumour
cell lines: MCF-7 (breast adenocarcinoma), NCI-H460 (non-small cell
lung cancer), HeLa (cervical carcinoma) and HepG2 (hepatocellular
carcinoma), as described elsewhere (Barros et al., 2013; Dias et al.,
2013).
The hepatotoxicity was evaluated against non-tumour porcine liver
primary cells (PLP2). This cell culture was prepared from freshly har-
vested porcine liver obtained from a local slaughter house, as described
(Barros et al., 2013; Dias et al., 2013). The SRB assay was performed
according to the procedure previously described (Barros et al., 2013;
Dias et al., 2013). In all cases the results are expressed in GI50 values,
which correspond to the concentration that inhibits 50% of cell growth.
Ellipticine was used as standard.
2.6. Statistical analysis
All the assays were carried out in duplicate. The results are ex-
pressed as mean values and standard deviation. The results were ana-
lysed using a Student´s t-test to determine the signiﬁcant diﬀerence
Table 1
1H and 13C NMR data of apigenin-6-C-glucoside (1) and lutelin-6-C-glucoside
(2) in CD3COD (1H 500MHz, 13C 125MHz)a.
Compound 1 2
position δC, type δH (J in Hz) δC, type δH (J in Hz)
2 164.8, C 164.9, C
3 102.5, CH 6.64, s 102.5, CH 6.57, s
4 182.7, C 182.6, C
4a 103.8, C 103.8, C
5 160.7, C 160.6, C
6 107.8, C 107.8, C
7 163.6, C 163.6, C
8 93.8, CH 6.54, s 93.8, CH 6.51, s
8a 157.3, C 157.3, C
1' 121.7, C 122.1, C
2' 128.1, CH 7.87, d (8.7) 112.7, CH 7.39, br s
3' 115.6, CH 6.95, d (8.7) 145.7, C
4' 161.4, C 149.7, C
5' 115.6, CH 6.95, d (8.7) 115.4, CH 6.92, d (8.2)
6' 128.1, CH 7.87, d (8.7) 118.9, CH 7.40, dd (1.9, 8.2)
1" 73.9, CH 4.93, d (9.2) 73.9, CH 4.92, d (9.2)
2" 71.1, CH 4.19, ddd (9.2, 7.0,
2.2)
71.2, CH 4.19, ddd (9.2, 7.0,
2.2)
3" 78.7, CH 3.50, m 78.7, CH 3.50, m
4" 70.4, CH 3.50, m 70.4, CH 3.50, m
5" 81.2, CH 3.44, m 81.2, CH 3.44, m
6" 61.4, CH2 3.89, dd (1.9, 12.1) 61.5, CH2 3.90, dd (2.2, 12.1)
3.76, dd (5.4, 12.1) 3.76, dd (5.4, 12.1)
a For atom numbering see Fig. 1.
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among the diﬀerent samples, with α=0.05, using IBM SPSS Statistics
for Windows, version 23.0. (IBM Corp., Armonk, NY, USA).
3. Results and discussion
3.1. Isolation and structural elucidation of the compounds
The selection of the fractions to be separated was performed fol-
lowing two requirements: on one hand, they should display the best
cytotoxic activity amongst the obtained fractions and, on the other,
they should be available in amounts that would potentially furnish the
compounds to be isolated in manageable amounts. The acetone frac-
tions FA4, FA5 and FA6 previously obtained (Graça et al., 2018) were
chosen for complying these two criteria. The separation of these frac-
tions by semipreparative HPLC, using 1% aqueous formic acid and
MeOH, allowed the isolation of two ﬂavone glycosides, apigenin-6-C-
glucoside (1) and lutelin-6-C-glucoside (2), and a mixture of the two
anomeric forms of 2,3-dygalloyl-4,6-HHDP-D-glucose [2,3-dygalloyl-
4,6-HHDP-α-D-glucose (3a) and 2,3-dygalloyl-4,6-HHDP-β-D-glucose
(3b)] (Fig. 1). This is the ﬁrst time that these compounds were isolated
from G. molle, and, to the best of our knowledge, from a Geranium
species.
The full structural elucidation of the isolated compounds was es-
tablished unequivocally on the basis of the corresponding 1H- and 13C-
NMR spectra (Tables 1 and 2) together with 2D experiments (HSQC,
HMBC and COSY) (Supporting Information).
Apigenin-6-C-glucoside (1): 1H-1H COSY (Figure 3S) underlined the
scalar correlations in the glucose unit: H1” (anomeric proton at
4.93 ppm) - H2” (4.19 ppm) - H3” (3.50 ppm) - H4” (3.50 ppm) - H5”
(3.43 ppm) - H6” (diastereotopic protons at 3.76 and 3.89 ppm). The
diasterotopic protons H6” in the methylene group were evidenced in
1H-13C HSQC by their common correlation with the carbon C6” at
61.4 ppm (Figure 4S). The anomeric proton H1” presents a coupling
constant value 3J1”-2”=9.2 Hz, proving its axial position, and hence the
β-glucose conformation. H1” is attached to C1” at 73.9 ppm, itself
bonded to one carbon of the ﬂavone skeleton, C6 at 107.8 ppm. Such
junction was showed in 1H-13C HMBC thanks to long-range correlations
observed between H1” and C5 (160.7 ppm) and C7 (163.6 ppm), and
between H8 at 6.54 ppm (singlet) and C6 (107.8 ppm) and C4a
(103.8 ppm). From C4a, H3 was attributed to the singlet at 6.64 ppm,
itself correlated through three bonds to carbon C1’ at 121.7 ppm.
Finally, the two doublets at 7.87 (I= 2H) and 6.95 (I= 2H) ppm with
a coupling constant 3J=8.7 Hz were assigned to H2’/6’ and H3’/5’, re-
spectively, of the p-hydroxybenzene ring.
Lutelin-6-C-glucoside (2): NMR spectra indicated that the structure
of 2 is very similar to that of 1, with the exception of the benzene ring of
the ﬂavone, substituted in 2 with 2 OH groups in 3’ and 4’ positions.
This was evidenced by three signals in the 1H NMR spectrum (Figure
6S): H2’ (7.39 ppm, d, 4J2’-6’ = 1.9 Hz, I= 1H), H5’ (6.92 ppm, d,
3J5’-6’=8.2 Hz, I= 1H) and H6’ (7.40 ppm, dd, 3J5’-6’=8.2 Hz,
4J2’-6’=1.9 Hz, I= 1H).
Anomeric isomers of 2,3-dygalloyl-4,6-HHDP-D-glucose (3a/3b): In
the 1H spectrum (Figure 11S), two sets of signals could be observed. The
major isomer (60%) is 2,3-dygalloyl-4,6-HHDP-α-D-glucose (3a). The α-
conformation is proved by the coupling constant value 3J=3.8 Hz
measured in the doublet of the anomeric proton H1 at 5.51 ppm, which
is typical of an equatorial-axial coupling. H1 is attached to carbon C1 at
95.7 ppm, more deshielded than in compounds 1 and 2, due to its
substitution with an hydroxyl function. 1H-1H COSY (Figure 13S) un-
derlined the correlations in the glucose unit: H1 (5.51 ppm) - H2
(5.12 ppm) - H3 (5.86 ppm) - H4 (5.14 ppm) - H5 (4.67 ppm) - H6
(diastereotopic protons at 3.85 and 5.34 ppm, both attached to C6 at
62.9 ppm). In the 1H NMR spectrum, two singlets (I= 1H) were ob-
served at 6.52 ppm (H6’a) and at 6.64 ppm (H6”a) for the HHDP moiety
and two singlets (I= 2H) at 7.04 ppm (H2’/6’) and at 6.95 ppm (H2”/6”)
for the two galloyl ester groups. A 1H-13C HMBC experiment (Figure
15S) allowed to identify the positions of the attachment of HHDP and
galloyl ester groups to the glucose unit. Long-range correlations were
underlined between H6”a and C6H2 and C7”a at 168.4 ppm; between H6’a
and H4 and C7’a at 167.9 ppm; between H2’/6’ and H2 and C7’ at
166.1 ppm; and between H2”/6” and H3 and C7” at 166.5 ppm. Such
correlations proved that the HHDP moiety is attached to C4 and C6
while the two galloyl esters are linked to C2 and C3. The minor isomer
(40%) is the 2,3-dygalloyl-4,6-HHDP-β-D-glucose (3b). The β-con-
formation was identiﬁed from the doublet signal of the anomeric proton
H1 at 4.99 ppm with a coupling constant 3J1-2= 8.0 Hz, characteristic of
an axial-axial scalar coupling. Its structural elucidation was obtained
according to the same NMR procedure used for 3a.
The two ﬂavone glycosides 1 and 2, as well as the anomeric mixture
of 3a and 3b presented high resolution mass spectra in full accordance
with the proposed structures.
The attempt to separate the 3a and 3b by HPLC resulted in com-
binations of the same anomers with a composition similar to that of the
starting mixture. Most probably the conversion of one anomer into the
other occurred under the conditions of the chromatographic separation,
Table 2
1H and 13C NMR data of 2,3-dygalloyl-4,6-HHDP-α-D-glucose (3a) and 2,3-dy-
galloyl-4,6-HHDP-β-D-glucose (3b) in CD3COD (1H 500MHz, 13C 125MHz)a.
Compound 3a 3b
position δC, type δH (J in Hz) δC, type δH
1 90.4, CH 5.51, d (3.8) 95.7, CH 4.99, d (8.0)
2 72.2, CH 5.12, dd (3.8,
10.0)
73.4, CH 5.21, dd (8.2,
9.6)
3 70.6, CH 5.86, t (9.8) 72.9, CH 5.62, t (9.8)
4 70.6, CH 5.14, t (10.2) 70.3, CH 5.17, t (10.2)
5 66.2, CH 4.67, dd (6.6,
10.2)
71.4, CH 4.23, dd (6.6,
10.2)
6 62.9, CH2 5.34, dd (6.4,
13.1)
62.8, CH2 5.37, dd (6.4,
13.1)
3.85, d (13.1) 3.93, d (13.1)
1' 119.2, C 119.2, C













6' 109.0, CH 7.04, s 109.0, CH 7.02, s
7' 166.1, C 165.7, C
1" 119.4, C 119.5, C













6" 109.0, CH 6.95, s 109.0, CH 6.91, s
7" 166.5, C 166.3, C
1'a 115.0, C 115.0, C





4'a 144.5, C 144.5, C
5'a 143.4, C 143.4, C
6'a 106.8, CH 6.52, s 106.8, CH 6.48, s
7'a 167.9, C 167.8, C
1"a 115.3, C 115.3, C





4"a 144.5, C 144.5, C
5"a 143.4, C 143.4, C
6"a 107.2, CH 6.64, s 107.2, CH 6.64, s
7"a 168.4, C 168.3C
a For atom numbering see Fig. 1.
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since anomerization of glycosides is known to easily take place in so-
lution (Tanaka et al., 2018). One interesting observation is the fact that
the two anomers showed a substantial diﬀerence in their hydro-
phobicity as they presented very diﬀerent retention times in the re-
versed phase column (Valkó et al., 1997), which can have inﬂuence in
the cytotoxicity of each anomer (Selassie et al., 2005).
3.2. Evaluation of cytotoxicity of the compounds
The cytotoxic properties of the compounds isolated from the
acetone fractions of G. molle were tested against four human tumour
cell lines: MCF-7 (breast adenocarcinoma), NCI-H460 (non-small cell
lung cancer), HeLa (cervical carcinoma) and HepG2 (hepatocellular
carcinoma). The hepatotoxicity was also evaluated using a porcine liver
primary cell culture (PLP2). The results are presented in Table 3.
Among the obtained compounds, the mixture of 2,3-digalloyl-4,6-
HHDP-α-D-glucose (3a) and 2,3-digalloyl-4,6-HHDP-β-D-glucose (3b)
was the one with the best cytotoxic activity against all the tested tu-
mour cell lines. The highest cytotoxic eﬀect was exhibited against MCF-
7 and HeLa cells (GI50= 22.32 and 25.57 μg/mL, respectively).
Conversely, this anomeric mixture also presented the highest toxicity
against normal primary cells from porcine liver (PLP2)
(GI50= 101.53 μg/mL). However, the concentration required to reach
50% of growth inhibition of PLP2 was, in some cases, about 3–4 times
higher than the concentration required to achieve 50% of growth in-
hibition of the human tumour cell lines tested. In this way, at the do-
sage of 61.21 μg/mL, the highest GI50 value found, the mixture 3a/3b
ensures 50% of growth inhibition of any of the cancer cell lines tested,
without signiﬁcant hepatotoxic eﬀects. Tellimagrandin I, as it is com-
monly denoted in the literature the ellagitannin with the 2,3-digalloyl-
4,6-HHDP-D-glucose structure in the form of an anomeric mixture of
undeﬁned proportion or undeﬁned anomeric carbon conﬁguration, has
been referred to possess anticancer activity both in vitro (Berdowska
et al., 2018; Le et al., 2014; Yi et al., 2006) and in vivo (Miyamoto et al.,
1987).
Luteolin-6-C-glucoside (2) showed poor to moderate cytotoxic
properties, being the highest cytotoxic activity exhibited against the
MCF-7 cell line with a GI50 value of 261.67 μg/mL. It should be em-
phasized, however, that this compound did not show signiﬁcant he-
patotoxicity against the PLP2 cell line up to the maximal tested con-
centration (GI50> 400 μg/mL). The antiproliferative properties of
luteolin-6-C-glucoside (2) have been previously reported (Conforti
et al., 2009; Gundogdu et al., 2018; Huang et al., 2018; Lin et al., 2016;
Paciﬁco et al., 2010; Shoeb et al., 2007; Ye et al., 2016; Yuan et al.,
2012, 2013, 2014).
Finally, apigenin-6-C-glucoside (1) showed to be relatively in-
eﬀective against all the tested cancer cell lines (GI50> 400 μg/mL).
Although compound 1 did not show cytotoxic activity against the cell
lines tested herein within the range of the assayed concentrations, it has
demonstrated to possess inhibitory activity against several types of
Fig. 1. Metabolites isolated from G. molle.
Table 3
Cytotoxic activity of the compounds isolated from the acetone fractions of G.
molle L..
Compound 1 2 3a/3b
Anticancer activity (GI50, μg/
mL)
MCF-7 >400 261.67 ± 0.28a 22.32 ± 0.41b
NCI-H460 >400 298.53 ± 8.93a 56.07 ± 5.30b
HeLa >400 304.07 ± 12.03a 25.57 ± 1.16b
HepG2 >400 318 ± 8.35a 61.21 ± 3.98c
Hepatotoxicity (GI50, μg/mL)
PLP2 >400 >400 101.53 ± 3.91a
GI50 values correspond to the sample concentration achieving 50% of growth
inhibition in human tumour cell lines or in liver primary culture PLP2.
Ellipticine GI50 values: 1.21 μg/mL (MCF-7), 1.03 μg/mL (NCI-H460), 0.91 μg/
mL (HeLa), 1.10 μg/mL (HepG2) and 2.29 μg/mL (PLP2). In each row diﬀerent
letters mean signiﬁcant diﬀerences (p< 0.05).
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cancer cells, as disclosed in a recent review (Ganesan and Xu, 2017).
Comparing the cytotoxicity of the isolated compounds with that of
the starting acetone fractions FA4, FA5 and FA6, it is apparent that the
cytotoxicity of the mixture 3a/3b against the tested tumour cell lines
(GI50 values from 22.32 to 61.21 μg/mL) is similar to that of FA4 (GI50
values from 14.5 to 55 μg/mL), from which it was isolated. Being those
the chief compounds of that fraction, it is reasonable to assume that
they are the main responsible for the cytotoxic properties displayed by
FA4. Contrarily, the cytotoxicity of the two ﬂavone glycosides 1 and 2 is
signiﬁcantly lower than that of the original acetone fractions FA5 and
FA6. In these cases, it seems plausible that a synergistic eﬀect of the
mixture of compounds present in each fraction accounts for the higher
cytotoxic eﬀect against the human tumour lines in comparison to those
of the single compounds.
4. Conclusions
Three fractions from G. molle, obtained by the bio-guided fractio-
nation of an acetone extract by gradient elution column chromato-
graphy, were subjected to semi-preparative HPLC. This puriﬁcation
process allowed the isolation of two ﬂavone glycosides, apigenin-6-C-
glucoside (1) and lutelin-6-C-glucoside (2), and an anomeric mixture of
2,3-dygalloyl-4,6-HHDP-D-glucose (3a/3b), for the ﬁrst time from G.
molle and, to the best of our knowledge, from a Geranium species.
The structural elucidation of the isolated compounds was estab-
lished unequivocally based on the corresponding 1H- and 13C-NMR
spectra, along with 2D experiments (HSQC, HMBC and COSY), and high
resolution mass spectra.
Apigenin-6-C-glucoside (1) and luteolin-6-C-glucoside (2) showed
poor to moderate cytotoxic properties, while the anomeric mixture of
2,3-digalloyl-4,6-HHDP-D-glucose (3a/3b) exhibited signiﬁcant cyto-
toxicity activity against the tested tumour cell lines, with only moderate
hepatotoxicity. The highest cytotoxic eﬀect was displayed against MCF-
7 and HeLa cells.
Unlike the two ﬂavone glycosides 1 and 2, for which the cytotoxic
activity against the cancer cell lines was signiﬁcantly lower than that of
the acetone fractions from which they were isolated, the cytotoxicity of
the mixture 3a/3b was similar to that of the original fraction. This
preservation of cytotoxicity suggests that this anomeric mixture of el-
lagitannins is the main responsible for the cytotoxic properties ex-
hibited by the original fraction.
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